Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzira influenza vaccine immunogenicity and safety study in healthy adults and older adults (2008/2009 season)
2008-001422-14Phase 4Completed
- Sponsor
- CSL Limited
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of omeprazole in influenza (2 arms), sponsored by CSL Limited. Primary endpoints: Primary immunogenicity endpoint and Safety endpoint. Started Mar 2008; status: completed.
02
Drugs
omeprazole
03
Conditions
influenza
Beyond the preview
Go deeper on 2008-001422-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001422-14.